Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Accelerated FDA Approval

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Feb 24, 2023 6:41pm

247 Views

Post# 35304641

RE:Accelerated FDA Approval

I agree Enriquesuave.. The clinical test results are great. Projected to be more effective than Keytruda is really impressive. Some kind of MD and A from our CEO or RDW into their plans for a JV would be a nice touch. Even if they are pre-liminary discussions with FDA on their BTD application would propel some action in the stock price. Reports from Analysts like Dr. Uddin have become kind of stale.

<< Previous

Bullboard Posts

Next >>

NTG Clarity Networks' growth story continues with $22M contract